MDCX vs VWAV

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Sep 24, 2026

MDCX

58.9
AI Score
VS
MDCX Wins

VWAV

37.5
AI Score

Investment Advisor Scores

MDCX

59score
Recommendation
HOLD

VWAV

38score
Recommendation
SELL

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric MDCX VWAV Winner
Net Income -20.66M -45.78M MDCX
Operating Income -20.08M -35.77M MDCX
ROE 1171.4% -35.3% MDCX
ROA -76.2% -25.5% VWAV
Total Assets 27.12M 179.80M VWAV
Cash 15.17M 26,186 MDCX
Current Ratio 1.57 0.16 MDCX

Relative Price Performance (Last 90 Days)

MDCX 1M: -0.5% · 3M: -61.5% VWAV 1M: +604.0% · 3M: +1.5%

Current Technical Phase

MDCX

Markdown
Sell / avoid

Price below a falling SMA50 (slope -29.7%), weak momentum, RSI 40

RSI (14): 40.4 · Price: $0.17

VWAV

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 63

RSI (14): 63.5 · Price: $4.30

Fundamentals Snapshot

Metric MDCX VWAV
Market Cap — —
Forward P/E -0.6 0.0
Trailing P/E — —
Revenue (TTM) — —
Revenue Growth 0.0% 0.0%
Gross Margin — 0.4%
Operating Margin 0.0% -63.4%
EPS -2.33 -26.17
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, MDCX is currently the stronger investment candidate, winning 5 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.